Leydig, Voit & Mayer has an impressive team of professionals – many with advanced degrees – actively engaged in biotechnology patent work. Our biotechnology clients range from start-ups to multi-national corporations and include the prestigious National Institutes of Health, as well as numerous universities located in the United States, Europe, and Japan. We address the needs of our diverse biotechnology clients not only through the use of our extensive patent experience, but also by ensuring that we fully understand both the science and business goals of our clients.
Our services in the biotechnology practice area include patent landscape evaluations, rendering freedom-to-operate (infringement clearance) opinions, structuring entire biotechnology patent portfolios, drafting and prosecuting patent applications, providing legal advice concerning the validity and enforceability of patents, preparing licenses and other agreements, and handling patent interferences, oppositions, and litigation.
While we are currently handling or have handled substantially every type of subject matter within the field of biotechnology, particular subject matters include nucleic acid sequences, proteins, antibodies, cell lines, vectors, and vaccines, with end-uses ranging from diagnostic assays to treatment methods to industrial processes.